The global public health community has set ambitious treatment targets to end the HIV/AIDS
pandemic. With the notable absence of a cure, the goal of HIV treatment is to achieve …

Introduction Routine viral load monitoring for HIV‐1 management of persons on antiretroviral
therapy (ART) has been recommended by the World Health Organization (WHO) to identify …

Background HIV-1 viral load testing is recommended to monitor antiretroviral therapy (ART)
but is not universally available. The aim of our study was to assess monitoring of first-line …

Background The number of patients in need of second-line antiretroviral drugs is increasing
in sub-Saharan Africa. We aimed to project the need of second-line antiretroviral therapy in …

There is no viable substitute for re-energizing, funding and supporting culturally attuned,
locally staffed HIV advocacy and prevention programmes, especially in resource poor …

Introduction HIV viral load (VL) is accepted as a key biomarker in HIV transmission and
pathogenesis. This paper presents a review of the role of VL testing in mathematical models …

ABSTRACT Although Roche COBAS Ampliprep/COBAS TaqMan (CAP/CTM) systems are
widely used in sub-Saharan Africa for early infant diagnosis of HIV from dried blood spots …

Background HIV-1 viral load (VL) testing is recommended to monitor antiretroviral therapy
(ART) but not universally available. We examined monitoring of first-line and switching to …

Summary Objectives The 90‐90‐90 target states that by 2020, 90% of people living with HIV
should be diagnosed, 90% of those diagnosed treated, and 90% of those treated virally …

Quinze ans après la mise en place et l'accès élargi au traitement antirétroviral (TAR) dans
les pays du Sud, la suppression virale, objectif clé de son efficacité, n'est pas atteinte chez …